lercaril 20 mg/10 mg film-coated tablets
imed healthcare ltd. - lercanidipine hydrochloride; enalapril maleate - film-coated tablet - ace inhibitors and calcium channel blockers; enalapril and lercanidipine
zanipress 20mg/20mg film-coated tablets
recordati ireland limited raheens east, ringaskiddy co. cork, ireland - enalapril maleate, lercanidipine hydrochloride - film-coated tablet - enalapril maleate 20 mg lercanidipine hydrochloride 20 mg - agents acting on the renin-angiotensin system
coripren tablets film-coated
recordati industria chimica e farmaceutica s.p.a. - lercanidipine (lercanidipine hydrochloride), enalapril (enalapril maleate) - tablets film-coated - 10mg+ 20mg
coripren tablets film-coated
recordati industria chimica e farmaceutica s.p.a. - lercanidipine (lercanidipine hydrochloride), enalapril (enalapril maleate) - tablets film-coated - 10mg+ 10mg
coripren tablets film-coated
recordati industria chimica e farmaceutica s.p.a. - lercanidipine (lercanidipine hydrochloride), enalapril (enalapril maleate) - tablets film-coated - 10mg+ 10mg
coripren tablets film-coated
recordati industria chimica e farmaceutica s.p.a. - lercanidipine (lercanidipine hydrochloride), enalapril (enalapril maleate) - tablets film-coated - 10mg+ 20mg
nortrel 21 day- norethindrone and ethinyl estradiol tablet nortrel 28 day- norethindrone and ethinyl estradiol kit
teva pharmaceuticals usa, inc. - norethindrone (unii: t18f433x4s) (norethindrone - unii:t18f433x4s), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - norethindrone 1 mg - nortrel 1/35 and nortrel 0.5/35 tablets are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant® system depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. % of women experiencing an unintended pregnancy within the first year of use % of women continuing use at one year1 method (1) typical use2 (2) perfect use3 (3) (4) chance4 85 85 spermicides5 26 6 40 periodic abstinence 25 63 calendar 9 ovulation method 3 sympto-thermal6 2 post-ovulation 1 cap7 parous women 40 26 42 nulliparous women 20 9 56 sponge parous women 40 20 42 nulliparous women 20 9 56 diaphragm7 20 6 56 withdrawal 19 4 condom8 female (r
nortrel 28 day- norethindrone and ethinyl estradiol kit
a-s medication solutions - norethindrone (unii: t18f433x4s) (norethindrone - unii:t18f433x4s), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - nortrel 1/35 and nortrel 0.5/35 tablets are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant® system depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. % of women experiencing an unintended pregnancy within the first year of use % of women continuing use at one year1 method (1) typical use2 (2) perfect use3 (3) (4) chance4 85 85 spermicides5 26 6 40 periodic abstinence 25 63 calendar 9 ovulation method 3 sympto-thermal6 2 post-ovulation 1 cap7 parous women 40 26 42 nulliparous women 20 9 56 sponge parous women 40 20 42 nulliparous women 20 9 56 diaphragm7 20 6 56 withdrawal 19 4 condom8 female (r
nortrel 7/7/7 (28 day regimen)- norethindrone and ethinyl estradiol kit
teva pharmaceuticals usa, inc. - norethindrone (unii: t18f433x4s) (norethindrone - unii:t18f433x4s), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - norethindrone 0.5 mg - nortrel® 7/7/7 (norethindrone and ethinyl estradiol tablets usp, 0.5/0.035 mg, 0.75/0.035 mg, and 1/0.035 mg) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant® system depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. table 1: percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception and the percentage continuing use at the end of the first year. united states. % of women experiencing an unintended pregnancy within the first year of use % of women continuing use at one year1 method (1) typical use2 (2) perfect use3 (3)
nortrel 7/7/7 (28 day regimen)- norethindrone and ethinyl estradiol kit
proficient rx lp - norethindrone (unii: t18f433x4s) (norethindrone - unii:t18f433x4s), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - nortrel® 7/7/7 (norethindrone and ethinyl estradiol tablets usp, 0.5/0.035 mg, 0.75/0.035 mg, and 1/0.035 mg) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant® system depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. table 1: percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception and the percentage continuing use at the end of the first year. united states. % of women experiencing an unintended pregnancy within the first year of use % of women continuing use at one year1 method (1) typical use2 (2) perfect use3 (3)